Hou Wanyin, Dong Jie
Department of Nephrology, Peking University First Hospital; Institute of Nephrology, Peking University; Key Lab of Renal Disease, Ministry of Health of China; Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing 100034, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Jun 18;56(3):546-550. doi: 10.19723/j.issn.1671-167X.2024.03.024.
Spontaneous renal cyst hemorrhage is one of the clinical emergencies in peritoneal dialysis (PD) patients and is potentially life-threatening. The main complaints are sudden low back pain, paleness, and hypotensive shock with or without vomiting or fever. In contrast to inherited polycystic kidney disease, acquired cystic kidney disease (ACKD) secondary to chronic kidney disease is easily overlooked or delayed in clinical diagnosis and treatment, leading to severe clinical outcomes. We report three patients with spontaneous hemorrhage of ACKD in the peritoneal dialysis center at Peking University First Hospital. The common features are as follows, long history of dialysis, mild to severe low back pain, decrease in hemoglobulin, negative PD solutions, diagnosis established through computed tomography (CT), and continuing PD during treatment of ACKD hemorrhage. Treatments vary from conservative to unilaterally selective renal artery embolization. In this study, ACKD morbidity was investigated in PD patients. A total of 316 patients who had an abdominal ultrasound, CT, or magnetic resonance imaging (MRI) in the past 1 year were enrolled. Among them, 103 cases (32.9%) met the diagnostic criteria of ACKD. The morbidity rates were 27.5%, 37.8%, 43.8%, 59.1%, and 88.6%, when the dialysis history ranged from ≤3, >3 & ≤5, >5 & ≤7, >7 & ≤9, >9 years, respectively, showing a increasing trend. Most ACKD hemorrhages could be healed and got an acceptable prognosis after treatment, including rest, blood transfusion, selective renal artery embolization, or nephrectomy. We summarize the risk factors, including a long history of dialysis, anticoagulation or antiplatelet, and inflammation or stones of the urinary system, but with no difference in initial kidney diseases and gender. ACKD hemorrhage mainly includes intracapsular hemorrhage, cyst rupture, and spontaneous retroperitoneal hemorrhage. In addition, we also recommend an adaptive process for spontaneous kidney hemorrhage of diagnosis and treatment in peritoneal dialysis patients. The significance of these cases lies in the fact that patients with ACKD are potentially associated with complications such as cyst hemorrhage and malignancy. Thus, peritoneal dialysis physicians should place great importance on the surveillance of ACKD.
自发性肾囊肿出血是腹膜透析(PD)患者的临床急症之一,有潜在生命危险。主要症状为突发腰痛、面色苍白,伴或不伴有呕吐或发热的低血压休克。与遗传性多囊肾病不同,继发于慢性肾脏病的获得性肾囊肿病(ACKD)在临床诊断和治疗中容易被忽视或延误,导致严重的临床后果。我们报告北京大学第一医院腹膜透析中心3例ACKD自发性出血患者。共同特点如下:透析病史长,轻至重度腰痛,血红蛋白降低,腹膜透析液阴性,通过计算机断层扫描(CT)确诊,ACKD出血治疗期间继续腹膜透析。治疗方法从保守治疗到单侧选择性肾动脉栓塞不等。本研究对PD患者中ACKD的发病率进行了调查。共纳入316例在过去1年接受过腹部超声、CT或磁共振成像(MRI)检查的患者。其中,103例(32.9%)符合ACKD诊断标准。当透析病史分别为≤3年、>3年且≤5年、>5年且≤7年、>7年且≤9年、>9年时,发病率分别为27.5%、37.8%、43.8%、59.1%和88.6%,呈上升趋势。大多数ACKD出血经治疗后可愈合,预后尚可,治疗方法包括休息、输血、选择性肾动脉栓塞或肾切除术。我们总结了危险因素,包括透析病史长、抗凝或抗血小板治疗、泌尿系统炎症或结石,但初始肾病和性别无差异。ACKD出血主要包括囊内出血、囊肿破裂和自发性腹膜后出血。此外,我们还推荐了腹膜透析患者自发性肾出血的诊断和治疗适应流程。这些病例的意义在于ACKD患者可能与囊肿出血和恶性肿瘤等并发症相关。因此,腹膜透析医生应高度重视ACKD的监测。